INTRODUCTION
The view that stress may influence immune function (Bartrop, Lazarus, & Luckhurst, 1977; Laudenslager, Ryan, Drugan, Hyson, & Marei, 1983; Shavit, Terman, Martin, Lewis, Liebeskind, & Gale, 1985; Lewis, 1985) has led to the investigation of possible modulatory effects on various immune functions of products released by the central nervous system (CNS) after a stressful stimulus.
Accumulating evidence indicates that the opioid peptides B-endorphin (PE) and ACTH, both of which are derived from the precursor molecule pro-opiomelanocortin (POMC), are important candidates in this respect. The presence on lymphocytes of specific receptors for ACTH and the nonopiate part of the BE molecule has been described, suggesting the possibility that these neuropeptides can influence directly cells of the immune system (Bost, Smith, Wear, & Blalock, 1987; Schweigerer, Schmidt, Teschemacher, & Gramsch, 1985; Hazum, Chang, & Cuatrecasas, 1979) . The existence of opiate receptors on leukocytes is less clear. Mehrishi and Mills (1983) reported the presence of such a receptor, whereas Mendelsohn, Kerchner, Culwell, and Ades (1985) were unable to demonstrate the opiate receptor on lymphocytes.
The neuropeptide /3E has been shown to enhance monocyte, lymphocyte, and neutrophil migration (Van Epps & Salan, 1984) and to increase NK cell function (Kay, Allen, Morley, 1984) as well as the production of interferon-y (IFN-y) (Brown & Van Epps, 1986) . Alvarez-Mon, Kehrl, and Fauci (1985) have demonstrated that ACTH can enhance the mitogen-induced immunoglobulin production 284 0889-1591187 $3.00
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